A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Cardiac Output, Low
A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
Heart Failure, Systolic
Heart Failure, Diastolic
Natriuretic Peptide, Brain
Ventricular Function, Left
Ventricular Dysfunction, Left
A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
Heart Defects, Congenital
Cardiac Pacing, Artificial
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
Angiotensin-Converting Enzyme Inhibitors
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.
A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
Disease Models, Animal
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
Severity of Illness Index
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Predictive Value of Tests
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)
Kidney Failure, Chronic
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Atrial Natriuretic Factor
Sympathetic Nervous System
The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system.
Impaired conduction of cardiac impulse that can occur anywhere along the conduction pathway, such as between the SINOATRIAL NODE and the right atrium (SA block) or between atria and ventricles (AV block). Heart blocks can be classified by the duration, frequency, or completeness of conduction block. Reversibility depends on the degree of structural or functional defects.
The pressure within a CARDIAC VENTRICLE. Ventricular pressure waveforms can be measured in the beating heart by catheterization or estimated using imaging techniques (e.g., DOPPLER ECHOCARDIOGRAPHY). The information is useful in evaluating the function of the MYOCARDIUM; CARDIAC VALVES; and PERICARDIUM, particularly with simultaneous measurement of other (e.g., aortic or atrial) pressures.
Proportional Hazards Models
Pulmonary Wedge Pressure
Mineralocorticoid Receptor Antagonists
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
Failure to Thrive
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
Cardiac Resynchronization Therapy
Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY.
Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.
Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
Death, Sudden, Cardiac
Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
Hypertrophy, Left Ventricular
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
Liver Failure, Acute
A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.
Sarcoplasmic Reticulum Calcium-Transporting ATPases
Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
An abnormal pattern of breathing characterized by alternating periods of apnea and deep, rapid breathing. The cycle begins with slow, shallow breaths that gradually increase in depth and rate and is then followed by a period of apnea. The period of apnea can last 5 to 30 seconds, then the cycle repeats every 45 seconds to 3 minutes.
Receptors, Adrenergic, beta
Heart Arrest, Induced
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
Angiotensin II Type 1 Receptor Blockers
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
Dose-Response Relationship, Drug
Multiple Organ Failure
Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
Mitral Valve Insufficiency
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Method in which prolonged electrocardiographic recordings are made on a portable tape recorder (Holter-type system) or solid-state device ("real-time" system), while the patient undergoes normal daily activities. It is useful in the diagnosis and management of intermittent cardiac arrhythmias and transient myocardial ischemia.
Randomized Controlled Trials as Topic
Quality of Life
Ventricular Dysfunction, Right
A condition in which the RIGHT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE or MYOCARDIAL INFARCTION, and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the right ventricular wall.
A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.
Angiotensin Receptor Antagonists
Heart Valve Prosthesis
Autonomic Nervous System
The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.
A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another.
Sleep Apnea, Central
Rheumatic Heart Disease
A type of impedance plethysmography in which bioelectrical impedance is measured between electrodes positioned around the neck and around the lower thorax. It is used principally to calculate stroke volume and cardiac volume, but it is also related to myocardial contractility, thoracic fluid content, and circulation to the extremities.
Acute Kidney Injury
A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM.
American Heart Association
A response by the BARORECEPTORS to increased BLOOD PRESSURE. Increased pressure stretches BLOOD VESSELS which activates the baroreceptors in the vessel walls. The net response of the CENTRAL NERVOUS SYSTEM is a reduction of central sympathetic outflow. This reduces blood pressure both by decreasing peripheral VASCULAR RESISTANCE and by lowering CARDIAC OUTPUT. Because the baroreceptors are tonically active, the baroreflex can compensate rapidly for both increases and decreases in blood pressure.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Cause of Death
Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable.
A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.
Sodium Potassium Chloride Symporter Inhibitors
Drug Therapy, Combination
Myocardial Reperfusion Injury
Ventricular Function, Right
Reproducibility of Results
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
Receptors, Adrenergic, beta-1
A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). The adrenergic beta-1 receptors are equally sensitive to EPINEPHRINE and NOREPINEPHRINE and bind the agonist DOBUTAMINE and the antagonist METOPROLOL with high affinity. They are found in the HEART, juxtaglomerular cells, and in the central and peripheral nervous systems.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Glomerular Filtration Rate
A 21-amino acid peptide produced in a variety of tissues including endothelial and vascular smooth-muscle cells, neurons and astrocytes in the central nervous system, and endometrial cells. It acts as a modulator of vasomotor tone, cell proliferation, and hormone production. (N Eng J Med 1995;333(6):356-63)
Sensitivity and Specificity
Glycosides from plants of the genus DIGITALIS. Some of these are useful as cardiotonic and anti-arrhythmia agents. Included also are semi-synthetic derivatives of the naturally occurring glycosides. The term has sometimes been used more broadly to include all CARDIAC GLYCOSIDES, but here is restricted to those related to Digitalis.
Analysis of Variance
Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.
An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
Myocardial osteopontin expression coincides with the development of heart failure. (1/12919)To identify genes that are differentially expressed during the transition from compensated hypertrophy to failure, myocardial mRNA from spontaneously hypertensive rats (SHR) with heart failure (SHR-F) was compared with that from age-matched SHR with compensated hypertrophy (SHR-NF) and normotensive Wistar-Kyoto rats (WKY) by differential display reverse transcriptase-polymerase chain reaction. Characterization of a transcript differentially expressed in SHR-F yielded a cDNA with homology to the extracellular matrix protein osteopontin. Northern analysis showed low levels of osteopontin mRNA in left ventricular myocardium from WKY and SHR-NF but a markedly increased (approximately 10-fold) level in SHR-F. In myocardium from WKY and SHR-NF, in situ hybridization showed only scant osteopontin mRNA, primarily in arteriolar cells. In SHR-F, in situ hybridization revealed abundant expression of osteopontin mRNA, primarily in nonmyocytes in the interstitial and perivascular space. Similar findings for osteopontin protein were observed in the midwall region of myocardium from the SHR-F group. Consistent with the findings in SHR, osteopontin mRNA was minimally increased (approximately 1.9-fold) in left ventricular myocardium from nonfailing aortic-banded rats with pressure-overload hypertrophy but was markedly increased (approximately 8-fold) in banded rats with failure. Treatment with captopril starting before or after the onset of failure in the SHR reduced the increase in left ventricular osteopontin mRNA levels. Thus, osteopontin expression is markedly increased in the heart coincident with the development of heart failure. The source of osteopontin in SHR-F is primarily nonmyocytes, and its induction is inhibited by an angiotensin-converting enzyme inhibitor, suggesting a role for angiotensin II. Given the known biological activities of osteopontin, including cell adhesion and regulation of inducible nitric oxide synthase gene expression, these data suggest that it could play a role in the pathophysiology of heart failure. (+info)
Effects of amlodipine on sympathetic nerve traffic and baroreflex control of circulation in heart failure. (2/12919)Short-acting calcium antagonists exert a sympathoexcitation that in heart failure further enhances an already elevated sympathetic activity. Whether this is also the case for long-acting formulations is not yet established, despite the prognostic importance of sympathetic activation in heart failure. It is also undetermined whether in this condition long-acting calcium antagonists favorably affect a mechanism potentially responsible for the sympathetic activation, ie, the baroreflex impairment. In 28 heart failure patients (NYHA functional class II) under conventional treatment we measured plasma norepinephrine and efferent postganglionic muscle sympathetic nerve activity (microneurography) at rest and during arterial baroreceptor stimulation and deactivation induced by stepwise intravenous infusions of phenylephrine and nitroprusside, respectively. Measurements were performed at baseline and after 8 weeks of daily oral amlodipine administration (10 mg/d, 14 patients) or before and after an 8-week period without calcium antagonist administration (14 patients). Amlodipine caused a small and insignificant blood pressure reduction. Heart rate, left ventricular ejection fraction, and plasma renin and aldosterone concentrations were not affected. This was the case also for plasma norepinephrine (from 2.43+/-0.41 to 2.50+/-0.34 nmol/L, mean+/-SEM), muscle sympathetic nerve activity (from 54.4+/-5.9 to 51.0+/-4.3 bursts/min), and arterial baroreflex responses. No change in the above-mentioned variables was seen in the control group. Thus, in mild heart failure amlodipine treatment does not adversely affect sympathetic activity and baroreflex control of the heart and sympathetic tone. This implies that in this condition long-acting calcium antagonists can be administered without untoward neurohumoral effects anytime conventional treatment needs to be complemented by drugs causing additional vasodilatation. (+info)
Gender-related differences in myocyte remodeling in progression to heart failure. (3/12919)Gender-related differences responsible for the better prognosis of females with heart failure have not been clearly established. To address this issue, we investigated potential gender-related differences in myocyte remodeling in spontaneously hypertensive heart failure rats. Echocardiograms and myocyte growth were compared between males and females at compensated (2, 4, and 6 months) and decompensated (18 months in males and 24 months in females) stages of cardiac hypertrophy. Although left ventricular diastolic dimensions did not differ significantly between failing male and female rats, fractional shortening declined significantly only in failing males. Myocyte cross-sectional area did not change after 4 months of age in both genders, which is likely to be responsible for the absence of a change in left ventricular wall thickness during the progression to heart failure. Myocyte volume and cross-sectional area were significantly larger in males than females at 2, 4, and 6 months of age, although there were no significant differences at the failing stage. Reduced adaptive hypertrophic reserve was observed in males, which is likely to contribute to the higher morbidity and mortality of males with chronic heart failure. (+info)
Hereditary juvenile haemochromatosis: a genetically heterogeneous life-threatening iron-storage disease. (4/12919)Juvenile haemochromatosis is a rare inborn error of iron metabolism with clinical manifestations before 30 years of age. Unlike adult haemochromatosis which principally affects men, juvenile haemochromatosis affects the sexes equally; it causes early endocrine failure, dilated cardiomyopathy and joint disease. We report four patients (two of each sex) from three pedigrees affected by juvenile haemochromatosis with a mean onset at 22 years (range 14-30). All had endocrine deficiency with postpubertal gonadal failure secondary to pituitary disease; two suffered near-fatal cardiomyopathy with heart failure. Mean time to diagnosis from the first clinical signs of disease was 9.8 years (range 0.5-20) but general health and parameters of iron storage responded favourably to iron-depletion therapy. A 24-year-old man listed for heart transplantation because of cardiomyopathy [left ventricular (LV) ejection fraction 16%] responded to intravenous iron chelation with desferrioxamine combined with phlebotomy (ejection fraction 31%). A 27-year-old woman with subacute biventricular heart failure refractory to medication required orthotopic cardiac transplantation before the diagnosis was established (LV ejection fraction 25%). Genetic studies showed that these two patients with cardiomyopathy from unrelated families were heterozygous for the HFE 845G-->A (C282Y) mutation and wild-type at the H63D locus: complete sequencing of the intron-exon boundaries and entire coding sequence of the HFE gene failed to identify additional lesions. Two siblings in a pedigree without cardiomyopathy were wild-type at the HFE C282Y locus; although the brother harboured a single copy of the 187C-->G (H63D) allele, segregation analysis showed that in neither sibling was the iron-storage disease linked to MHC Class I markers on chromosome 6p. Juvenile haemochromatosis is thus a genetically heterogenous disorder distinct from the common adult variant. (+info)
Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. (5/12919)Norepinephrine (NE) reuptake function is impaired in heart failure and this may participate in myocyte hyperstimulation by the neurotransmitter. This alteration can be assessed by 123I-metaiodobenzylguanidine (MIBG) scintigraphy. METHODS: To determine whether the impairment of neuronal NE reuptake was reversible after metoprolol therapy, we studied 18 patients (43+/-7 y) with idiopathic dilated cardiomyopathy who were stabilized at least for 3 mo with captopril and diuretics. Patients underwent, before and after 6 mo of therapy with metoprolol, measurements of radionuclide left ventricular ejection fraction (LVEF), maximal oxygen consumption and plasma NE concentration. The cardiac adrenergic innervation function was scintigraphically assessed with MIBG uptake and release measurements on the planar images obtained 20 min and 4 h after tracer injection. To evaluate whether metoprolol had a direct interaction with cardiac MIBG uptake and release, six normal subjects were studied before and after a 1-mo metoprolol intake. RESULTS: In controls, neither cardiac MIBG uptake and release nor circulating NE concentration changed after the 1-mo metoprolol intake. Conversely, after a 6-mo therapy with metoprolol, patients showed increased cardiac MIBG uptake (129%+/-10% versus 138%+/-17%; P = 0.009), unchanged cardiac MIBG release and decreased plasma NE concentration (0.930+/-412 versus 0.721+/-0.370 ng/mL; P = 0.02). In parallel, patients showed improved New York Heart Association class (2.44+/-0.51 versus 2.05+/-0.23; P = 0.004) and increased LVEF (20%+/-8% versus 27%+/-8%; P = 0.0005), whereas maximal oxygen uptake remained unchanged. CONCLUSION: Thus, a parallel improvement of myocardial NE reuptake and of hemodynamics was observed after a 6-mo metoprolol therapy, suggesting that such agents may be beneficial in heart failure by directly protecting the myocardium against excessive NE stimulation. (+info)
Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. (6/12919)OBJECTIVE: To determine rates of morbidity due to cardiovascular and cerebrovascular diseases among women with systemic lupus erythematosus (SLE). METHODS: I used the California Hospital Discharge Database, which contains information on all discharges from acute care hospitals in California, to identify women with SLE who had been hospitalized for treatment of either acute myocardial infarction (AMI), congestive heart failure (CHF), or cerebrovascular accident (CVA) from 1991 to 1994. I compared the proportions of hospitalizations for each cause among women with SLE with those in a group of women without SLE, for 3 age strata (18-44 years, 45-64 years, and > or =65 years). RESULTS: Compared with young women without SLE, young women with SLE were 2.27 times more likely to be hospitalized because of AMI (95% confidence interval [95% CI] 1.08-3.46), 3.80 times more likely to be hospitalized because of CHF (95% CI 2.41-5.19), and 2.05 times more likely to be hospitalized because of CVA (95% CI 1.17-2.93). Among middle-aged women with SLE, the frequencies of hospitalization for AMI and CVA did not differ from those of the comparison group, but the risk of hospitalization for CHF was higher (odds ratio [OR] 1.39, 95% CI 1.05-1.73). Among elderly women with SLE, the risk of hospitalization for AMI was significantly lower (OR 0.70, 95% CI 0.51-0.89), the risk of hospitalization for CHF was higher (OR 1.25, 95% CI 1.01-1.49), and the risk of hospitalization for CVA was not significantly different from those in the comparison group. CONCLUSION: Young women with SLE are at substantially increased risk of AMI, CHF, and CVA. The relative odds of these conditions decrease with age among women with SLE. (+info)
QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion. (7/12919)OBJECTIVE: To compare QT dispersion in patients with impaired left ventricular systolic function and in matched control patients with normal left ventricular systolic function. DESIGN: A retrospective, case-control study with controls matched 4:1 for age, sex, previous myocardial infarction, and diuretic and beta blocker treatment. SETTING: A regional cardiology centre and a university teaching hospital. PATIENTS: 25 patients with impaired left ventricular systolic function and 100 patients with normal left ventricular systolic function. MAIN OUTCOME MEASURES: QT and QTc dispersion measured by three methods: the difference between maximum and minimum QT and QTc intervals, the standard deviation of QT and QTc intervals, and the "lead adjusted" QT and QTc dispersion. RESULTS: All measures of QT/QTc dispersion were closely interrelated (r values 0.86 to 0.99; all p < 0.001). All measures of QT and QTc dispersion were significantly increased in the patients with impaired left ventricular systolic function v controls (p < 0.001): 71.9 (6.5) (mean (SEM)) v 46.9 (1.7) ms for QT dispersion, and 83.6 (7.6) v 54.3 (2.1) ms(-1-2) for QTc dispersion. All six dispersion parameters were reduced in patients taking beta blockers (p < 0.05), regardless of whether left ventricular function was normal or impaired-by 9.4 (4.6) ms for QT dispersion (p < 0.05) and by 13.8 (6. 5) ms(-1-2) for QTc dispersion (p = 0.01). CONCLUSIONS: QT and QTc dispersion are increased in patients with systolic heart failure in comparison with matched controls, regardless of the method of measurement and independently of possible confounding factors. beta Blockers are associated with a reduction in both QT and QTc dispersion, raising the possibility that a reduction in dispersion of ventricular repolarisation may be an important antiarrhythmic mechanism of beta blockade. (+info)
Expression of skeletal muscle sarcoplasmic reticulum calcium-ATPase is reduced in rats with postinfarction heart failure. (8/12919)OBJECTIVE: To determine whether heart failure in rats is associated with altered expression of the skeletal muscle sarcoplasmic reticulum Ca2+-ATPase (SERCA). METHODS: SERCA protein and mRNA were examined in the soleus muscles of eight female rats with heart failure induced by coronary artery ligation, six weeks after the procedure (mean (SEM) left ventricular end diastolic pressure 20.4 (2.2) mm Hg) and in six sham operated controls by western and northern analyses, respectively. RESULTS: SERCA-2a isoform protein was reduced by 16% (112 000 (4000) v 134 000 (2000) arbitrary units, p < 0.001), and SERCA-2a messenger RNA was reduced by 59% (0.24 (0. 06) v 0.58 (0.02) arbitrary units, p < 0.001). Although rats with heart failure had smaller muscles (0.54 mg/g v 0.66 mg/g body weight), no difference in locomotor activity was observed. CONCLUSIONS: These results may explain the previously documented abnormalities in calcium handling in skeletal muscle from animals with the same model of congestive heart failure, and could be responsible for the accelerated muscle fatigue characteristic of patients with heart failure. (+info)
Acute kidney injury in pediatric acute decompensated heart failure<...
TY - JOUR. T1 - Acute kidney injury in pediatric acute decompensated heart failure. AU - Medar, Shivanand S.. AU - Hsu, Daphne T.. AU - Lamour, Jacqueline M.. AU - Aydin, Scott I.. PY - 2015/7/22. Y1 - 2015/7/22. N2 - Objective: Acute kidney injury in adult patients with acute decompensated heart failure is associated with increased mortality. There is limited literature in pediatric patients with acute decompensated heart failure and acute kidney injury. We aim to study acute kidney injury in the pediatric acute decompensated heart failure population and its association with specific outcomes. Design: Retrospective, case-control study. Setting: Cardiac ICU in a childrens tertiary care hospital. Patients: Index admissions of patients younger than 21 years with acute decompensated heart failure between January 2008 and December 2012. Interventions: None. Measurements and Main Results: Index admissions of patients younger than 21 years with acute decompensated heart failure between January 2008 ...
Congestive Heart Failure Treatment Devices Market Size, Share And Forecasts To 2022: Grand View Research, Inc | The News Bee
http://www.grandviewresearch.com/industry-analysis/congestive-heart-failure-treatment-devices-market. Cardiac assist devices (CAD) held one of the largest shares in congestive heart failure treatment devices market due to the shortage of heart donors and technologically advanced cardiac assist devices in 2013. Additionally, reimbursement coverage for cardiac device implantation procedures is anticipated to provide this segment with growth platform.. North America dominated the overall market in terms of revenue owing to the increasing incidence rates of high blood pressure, arthritis, coronary artery disease leading to congestive heart failure. Moreover increasing patient awareness and improved healthcare infrastructure in the U.S. and Canada are expected to drive the market of this region at a rapid rate.. Get More Details About Congestive Heart Failure Treatment Devices Market ...
Heart Failure Treatment | Cardiokinetix
Learn more about CardioKinetix heart failure treatment options. Call us at (650) 364-7016 to receive more info on heart failure treatments.
Heart Failure Treatments | Crestor Heart Failure Lawyer
Information on various heart failure treatments. Read about heart failure treatment options or contact a Crestor heart failure lawyer today at (888) 335-6059.
Right Sided Heart Failure Treatment - Health Platform HealthPlatform.Cloud
Right Sided Heart Failure Treatment Medicomat HealthPlatform.Cloud Remote Diagnosis and Therapy for the Entire World. Now Everyone can be healthy with Medicomat HealthPlatform.Cloud Right Sided Heart Failure Treatment health platform. Protect yourself and your family from viruses, bacteria, illness and pain.
Heart Failure Treatment in Azamgarh - View Fees, Book Appointment Online | DoctoriDuniya
Heart Failure Treatment in Azamgarh near me. View fee, user feedback & book appointment with Heart Failure Treatment doctors on DoctoriDuniya
Management of acute decompensated heart failure | CMAJ
Volume overload is central to the pathophysiology of most episodes of acute decompensated heart failure. Elevated filling pressures are ultimately responsible for many of the signs and symptoms of heart failure. Consequently, the goals of care, particularly in the acute setting, include the relief of congestion. Most patients presenting with severe acute decompensated heart failure have a pulmonary capillary wedge pressure greater than 25 mm Hg.9 In addition, patients whose left and right filling pressures can be reduced during their hospital stay typically experience alleviation of symptoms.30 Patients whose B-type natriuretic peptide level decreases substantially between admission and discharge have a much reduced likelihood of repeat hospital admission.18. As a reflection of the critical role of congestion in acute decompensated heart failure, clinicians rely heavily on diuretic therapy. Of patients with acute decompensated heart failure followed in recent large registries, 90% received loop ...
Heart Failure News: Latest News and Updates on Heart Failure at News18
Get all the latest news and updates on Heart Failure only on News18.com. Read all news including political news, current affairs and news headlines online on Heart Failure today.
Advanced Heart Failure Clinic Available at UPMC Horizon - Western Pennsylvania Healthcare News
A cardiologist from the UPMC Heart and Vascular Institute has established an advanced heart failure clinic at UPMC Horizon.. Michael A. Mathier, MD, director of the UPMC Pulmonary Hypertension Program and Cardiovascular Fellowship Program, as well as medical director of the Community Outreach and Cardiovascular Health Program, operates the clinic at UPMC Horizon once a month. The clinic was designed to provide consultative services to UPMC Horizon physicians and offers an array of medical and surgical options for advanced heart failure patients ranging from medications, mechanical circulatory support devices and cardiac transplantation.. Dr. Mathier specializes in the care of patients with advanced heart failure, cardiac transplantation, and pulmonary hypertension. He is certified by the American Board of Internal Medicine in internal medicine, cardiology, advanced heart failure, and transplantation.. The advanced heart failure clinic at UPMC Horizon provides a connection to the UPMC Heart ...
Acute Decompensated Heart Failure - How is Acute Decompensated Heart Failure abbreviated?
ADHF - Acute Decompensated Heart Failure. Looking for abbreviations of ADHF? It is Acute Decompensated Heart Failure. Acute Decompensated Heart Failure listed as ADHF
New-Onset Heart Failure and Mortality in Hospital Survivors of Sepsis-Related Left Ventricular Dysfunction<...
TY - JOUR. T1 - New-Onset Heart Failure and Mortality in Hospital Survivors of Sepsis-Related Left Ventricular Dysfunction. AU - Vallabhajosyula, Saraschandra. AU - Jentzer, Jacob C.. AU - Geske, Jeffrey B.. AU - Kumar, Mukesh. AU - Sakhuja, Ankit. AU - Singhal, Akhil. AU - Poterucha, Joseph T.. AU - Kashani, Kianoush. AU - Murphy, Joseph G.. AU - Gajic, Ognjen. AU - Kashyap, Rahul. PY - 2017/7/19. Y1 - 2017/7/19. N2 - BACKGROUND:: The association between new-onset left ventricular (LV) dysfunction during sepsis with long-term heart failure outcomes is lesser understood. METHODS:: Retrospective cohort study of all adult patients with severe sepsis and septic shock between 2007 and 2014 that underwent echocardiography within 72?hours admitted to the intensive care unit. Patients with prior heart failure, LV dysfunction, and structural heart disease were excluded. LV systolic dysfunction was defined as LV ejection fraction ,50% and LV diastolic dysfunction as ≥grade II. Primary composite outcome ...
MACH-1 - Mortality Assessment in Congestive Heart Failure (study; Journal of Clinical Cardiology) | AcronymFinder
How is Mortality Assessment in Congestive Heart Failure (study; Journal of Clinical Cardiology) abbreviated? MACH-1 stands for Mortality Assessment in Congestive Heart Failure (study; Journal of Clinical Cardiology). MACH-1 is defined as Mortality Assessment in Congestive Heart Failure (study; Journal of Clinical Cardiology) somewhat frequently.
Heart Failure Clinic
For the millions of people in the United States living with heart failure, managing the condition can be difficult. We recognizes that people with heart failure need extra time, medical attention and education to help keep them healthy and out of the hospital. To help, weve created the Little Company of Mary Heart Failure Clinic and its already helping area patients live a better life.. Clinic Offers Needed Time, Attention. Little Company of Mary Hospital opened the Heart Failure Clinic in May 2013. The clinic helps patients with severe heart failure, such as those who experience shortness of breath at rest or with minimal exertion. Heart failure often is a condition in which the hearts pumping ability is weak. As a result, its unable to pump enough blood to meet the bodys needs. People can develop the condition as a result of a heart attack, coronary heart disease, high blood pressure, kidney disease or other factors. Because people with heart failure often experience a domino effect of ...
The Effects of Vasodilator Therapy on Mortality in Chronic Congestive Heart failure - American College of Cardiology
Data suggest that the addition of hydralazine and isosorbide dinitrate to the therapeutic regimen of digoxin and diuretics in patients with chronic congestive heart failure can have a favorable effect on left ventricular function and mortality. (From Abstract). ...
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial - Full Text View - ClinicalTrials.gov
Cardiovascular mortality is decreasing in most industrial countries, however mortality for congestive heart failure is increasing. The most important predictors of mortality in heart failure patients are depressed left ventricular function, severity of symptoms (NYHA class), and ventricular conduction abnormality manifested as wide QRS. Recent advances in pharmacological therapy including ACE inhibitors, beta-blocker and spironolactone have resulted in improvement of symptoms and reduction in mortality. Population epidemiological studies demonstrated that mortality and hospitalization rate for heart failure remains very high despite recent pharmacological therapeutic progress. Recent short-term clinical trials demonstrated that cardiac resynchronization therapy (CRT) is effective in improving symptoms of heart failure, functional capacity and quality of life in patients with moderate to severe heart failure and conduction abnormality optimally treated with drug therapy. However, the data for ...
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial - Full Text View - ClinicalTrials.gov
Cardiovascular mortality is decreasing in most industrial countries, however mortality for congestive heart failure is increasing. The most important predictors of mortality in heart failure patients are depressed left ventricular function, severity of symptoms (NYHA class), and ventricular conduction abnormality manifested as wide QRS. Recent advances in pharmacological therapy including ACE inhibitors, beta-blocker and spironolactone have resulted in improvement of symptoms and reduction in mortality. Population epidemiological studies demonstrated that mortality and hospitalization rate for heart failure remains very high despite recent pharmacological therapeutic progress. Recent short-term clinical trials demonstrated that cardiac resynchronization therapy (CRT) is effective in improving symptoms of heart failure, functional capacity and quality of life in patients with moderate to severe heart failure and conduction abnormality optimally treated with drug therapy. However, the data for ...
HEART FAILURE MORTALITY IS INVERSELY RELATED TO WEALTH OF COUNTRY - Cyprus Larnaca Cardiology Center
Paris, France - 30 April 2017: Death in patients with heart failure is inversely related to the wealth of the country they live in, according to late breaking results from the INTERCHF study presented today at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure.1 Death rates in India and Africa were three to four times higher than those documented in Western countries.. Heart failure is a common condition that causes morbidity and mortality worldwide, said lead author Dr Hisham Dokainish, a principal investigator at the Population Health Research Institute (PHRI), McMaster University, Hamilton, Canada.. Most data on heart failure have come from Western countries but the majority of the worlds population lives elsewhere, he continued. This study was conducted to fill large gaps in knowledge about congestive heart failure in non-Western countries.. The International Congestive Heart Failure (INTERCHF) study was an observational cohort study that enrolled 5 823 patients with ...
Chronic heart failure still a major issue
The enormous costs of mortality and hospitalisation among patients with decompensated chronic heart failure needs to be faced head-on to avoid spiralling healthcare costs, delegates will be warned this morning.. This stark message will form part of the final in-depth session at Heart Failure 2016 looking at key sections of the new ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, developed with the Heart Failure Association (HFA).. This mornings symposium, which will focus on chronic heart failure and its management, will examine the issues surrounding the management of decompensated chronic heart failure, as well as changes in the management pathway of chronic heart failure patients in general.. Chaired by Gerasimos Filippatos (University of Athens, Greece) alongside Stefan D. Anker (University Medical Center Göttingen, Germany), this mornings session will emphasise the differences between the current recommendations for chronic heart failure and those ...
congestive heart failure | E-Healthy Living
By traditional methods, congestive heart failure treatment generally includes proper diet, a regimen of medicine and modified daily activities. For congestive heart failure treatment, there are a range of options. In a lot of cases surgery is the best congestive heart failure treatment. When a heart valve ceases to open .... Read More » ...
Health Group Warns Heart Failure Treatment Costs Will More Than Double By 2030 - Redorbit
April Flowers for redOrbit.com - Your Universe Online. The American Heart Association (AHA) issued a statement this week that predicts the number of people with heart failure could rise 46 percent - from 5 million in 2012 to 8 million in 2030 - and that the direct and indirect costs to treat heart failure could more than double -- from $31 billion in 2012 to $70 billion in 2030. This means every US taxpayer could be paying $244 a year to care for heart failure patients by 2030. The statement was published online in the journal Circulation: Heart Failure.. If we don´t improve or reduce the incidence of heart failure by preventing and treating the underlying conditions, there will be a large monetary and health burden on the country, said Paul A. Heidenreich, MD, MS, a professor of medicine at Stanford University School of Medicine.. The costs will be paid for by every adult in this country, not just every adult with heart failure, said Heidenreich, who is also director of the Chronic Heart ...
Congestive heart failure treatment | Angioplasty surgery in Mumbai
Best Congestive heart failure treatment under experts guidance is available at Asian Heart Institute. For Heart Valve replacement surgery, Visit here.
Heart failure treatment
Heart failure treatment is only able to reduce the symptoms as heart failure is a chronic disease. Treatment depends on your symptoms and the cause.
The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice<...
TY - JOUR. T1 - The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice. AU - Pont, Lisa G.. AU - Van Gilst, Wiek H.. AU - Lok, Dirk J A. AU - Kragten, Hans J A. AU - Haaijer-Ruskamp, Flora M.. PY - 2003/3. Y1 - 2003/3. N2 - Aims: Internationally, research indicates that pharmacotherapy for chronic heart failure (CHF) is sub-optimal. Traditionally, assessment of drug use in heart failure has focused on the use of individual agents irrespective of CHF severity. This study investigates drug use for CHF patients in general practice with respect to the available evidence, incorporating both disease severity and the use of combination drug regimes. Methods and results: A cross-sectional survey of 769 Dutch CHF patients was performed as part of IMPROVEMENT of HF study. For each New York Heart Association severity classification the minimum treatment appropriate for the heart failure severity according to the scientific evidence available at the ...
Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic...
Whereas cardiac cachexia is well recognized, the frequency and hemodynamic correlates of malnutrition in severe congestive heart failure (CHF) have not been established. Anthropometric and serum albumin assessment of nutritional status was compared with hemodynamic, echocardiographic and serum chemi …
Anemia and renal dysfunction in patients with ambulatory heart failure at the Kenyatta national hospital
Background. Many patients with chronic heart failure (CHF) fail to respond to maximal heart failure therapy and progress to end stage heart failure with frequent hospitalizations, poor quality of life and chronic renal insufficiency which leads to progressive chronic kidney disease (CKD) due to long standing renal vasoconstriction. These patients may also die of cardiovascular complications within a short time. Anemia is common in both heart failure and chronic kidney disease and is associated with a marked increase in mortality and morbidity in both conditions. Greater CHF severity has been observed in patients with lower hemoglobin. A decrease in hemoglobin over time is associated with an increase in left ventricular mass and higher mortality. Each of these conditions, that is, anemia, chronic renal insufficiency and heart failure can cause or worsen the other and this vicious circle is known as the Cardio Renal Anemia syndrome (CRAS). This study proposed to document the prevalence of anemia ...
LVAD and Heart Failure Management | Holy Cross Hospital
Holy Cross Hospital is a designated LVAD (Left Ventricular Assist Device) shared care facility in South Florida. We help previously end stage heart failure patients through LVAD, cardiac and heart failure management while they are traveling or moving to South Florida, away from their implantation sites. Located in Broward County, we work closely with implant sites around the United States to ensure good quality of life and peace of mind for you as you travel ...
New in the Literature: Heart Failure Treatment Costs Expected to Double by 2030 (Circ Heart Fail. 2013;Apr 24 [Epub])
By 2030, several million more people will suffer from heart failure, and related total treatment costs will more than double, from 2012 levels, says the American Heart Association (AHA) in a policy statement published online April 24 ahead of print in Circulation: Heart Failure.. AHA estimated future costs of heart failure (HF) using a methodology that it developed to project the epidemiology and future costs of HF from 2012 to 2030. The model did not double-count costs associated with comorbid conditions and assumed that heart failure rates based on sex, age, and race/ethnicity will not vary, and increasing costs and technological innovation will not vary. AHA projected that by 2030, more than 8 million people will suffer from heart failure; real total direct medical costs related to heart failure will increase from $21 billion to $53 billion; and total treatment costs will increase from $31 billion to $70 billion.. The statement authors concluded, The estimated prevalence and cost of care ...
Heart Failure Treatment in Richmond, VA | Henrico Doctors
Our cardiac team in Richmond provides comprehensive heart failure treatment, helping patients manage their symptoms and regain quality of life.
ഹൃദയ ശസ്ത്രക്രിയയും ഹൃദയം മാറ്റി വയ്ക്കലും വേണ്ട | Heart failure Treatment in Ayurveda , Heart failure treatment,...
എന്റെ പേര് ശശി , 60 വയസ്സുള്ള ഞാൻ സ്വന്തമായി കാന്റീൻ നടത്തുകയാണ്. 10 അടി നടന്നാൽ കാലു കഴപ്പും നട്ടെല്ല് മുറിയുന്നതുപോലെ വേദനയും, നെഞ്ചിൽ പുകച്ചിലും , കിതപ്പും, കുമ്പിട്ടാൽ കണ്ണ് മൂടലും, തലകറക്കവും , ശരീരം മുഴുവൻ ചൂടും, നെഞ്ച് വേദനയും, നെഞ്ചിടിപ്പും, നെഞ്ചെരിചിലും , നെഞ്ചിൽ ഭാരവും കലശലായി ഉണ്ടായിരുന്നു. എന്റെ ഹൃദയ മസിലിനു ബലക്ഷയം ഉണ്ടെന്നും , ഹൃദയത്തിലേക്കും , തലയിലേക്ക് പോകുന്ന ...
Body Composition in Experimental Congestive Heart Failure | Circulation Research
The bodies of four dogs with experimental congestive heart failure and of four normal dogs were homogenized. Analyses for water, fat, sodium, potassium, chloride, and nitrogen were carried out after discarding ascitic fluid in the animals with heart failure. Sodium and chloride concentrations were increased in dogs with heart failure. Otherwise the two groups did not differ significantly.. ...
Heart Failure Management « Heartscore
2. Heart failure genetic profiles - tells you if your patients are heading to a cliff or not. + 3. Super high fidelity ECG arrhythmia data analysis including A-Fib and QT Intervals!. Heartscores comprehensive heart failure management includes:. Heartscore NI Medical Cardiac Index and Stroke Volume - http://heartscore.co/nimedical/. Viviquant High Fidelity ECG Analysis, Arrhythmia Detection, A-Fib Analysys - http://www.vivaquant.com/. Heart failure genetic testing - determines likely path of disease progression - http://www.heartgenomics.com/products.html,. ProStem Ischemia Detection Test. Issys - Intelligent LVAD and Implantable Hemodynamic Sensor - http://mems-issys.com/nih-congestive-heart-failure/. Cardiobridge - Circulatory Assist Pump on a Catheter - www.cardiobridge.com. Procyron - Circulatory Assist Pump Device Implantable - www.procyrion.com. BioLeonhardt MyoStim - Implantable stem cell/growth factor pump + regeneration stimualtor www.bioleonhardt.com + www.myostimpacers.com Edema Sock ...
Nationwide Frequency and Association of Heart Failure on Stroke Outcomes in the United States<...
TY - JOUR. T1 - Nationwide Frequency and Association of Heart Failure on Stroke Outcomes in the United States. AU - Divani, Afshin A. AU - Vazquez, Gabriela. AU - Asadollahi, Marjan. AU - Qureshi, Adnan I. AU - Pullicino, Patrick. PY - 2009/2/1. Y1 - 2009/2/1. N2 - Background: Few studies of the effect of heart failure (HF) on stroke outcomes have been published. This study was designed to determine the association of co-existing HF with in-hospital length-of-stay (LOS), cost, and mortality among acute stroke patients admitted to hospitals in the United States (US). Methods and Results: All patients with a primary diagnosis of stroke admitted to the US hospitals in calendar years 1995 and 2005 were extracted using the National Inpatient Sample (NIS) database. Patients were categorized based on a secondary diagnosis of HF. Patients demographics, LOS, in-hospital death, disposition, and hospitalization costs were determined. The odds ratio of in-hospital mortality rates for stroke patients with ...
The Impact of Exercise Training on Conduit Artery Wall Thickness and Remodeling in Chronic Heart Failure Patients<...
TY - JOUR. T1 - The Impact of Exercise Training on Conduit Artery Wall Thickness and Remodeling in Chronic Heart Failure Patients. AU - Maiorana, A.J.. AU - Naylor, Louise. AU - Exterkate, A.. AU - Swart, A.. AU - Thijssen, D.H.J.. AU - Lam, K.. AU - ODriscoll, G.. AU - Green, Daniel. PY - 2011. Y1 - 2011. N2 - Exercise training is an important adjunct to medical therapy in chronic heart failure, but the extent to which exercise impacts on conduit artery remodeling is unknown. The aim of this study was to evaluate the impact of aerobic and resistance exercise training modalities on arterial remodeling in patients with chronic heart failure. We randomized 36 untrained subjects with chronic heart failure to resistance training (58.8 +/- 3.5 years), aerobic training (61.3 +/- 2.8 years), or an untrained control group (64.4 +/- 2.4 years). Peak oxygen consumption during cycle ergometry increased after 12 weeks in both the resistance and aerobic training (P. AB - Exercise training is an important ...
TreatHF App Review: The ACC Takes on Heart Failure at the Point of Care - iMedicalApps
Heart failure has quickly become one of the top causes of morbidity and mortality accounting for 1 in 9 deaths. As patients with coronary artery disease live longer, survive myocardial infarctions, and bypass surgery, more live with heart failure. The disease has a staggering mortality rate of over 50% within 5 years of diagnosis. The most recent American College of Cardiology (ACC) guideline revised the terminology from the old systolic and diastolic heart failure to heart failure with preserved (HfpEF) or reduced (HFrEF) ejection fraction. The etiology and treatment of HFpEF and HFrEF are significantly different and both patients and providers can become confused on how to treat each condition. In 2017, the ACC released new heart failure guidelines that incorporated the new terminology and recent practice-changing evidence such as the PARADIGM-HF trial which demonstrated significant mortality reduction via the novel neprilysin inhibitor (ARNI), sacubitril. Recent updates have further ...
Hypertension May Increase Heart Failure Risk after child birth in women. - Lactonova Sports
women suffering from hypertension are at an increased risk of heart failure within the six weeks after delivery, also known as the postpartum period.. Heart failure is a leading cause of maternal morbidity and death, affecting relatively young reproductive-age women, especially among those with the presence of an additional disease or condition, such as hypertension.. The recent clinical research study found that although less than two per cent of all pregnancy-related hospitalisations occurred during the postpartum period, nearly 60 per cent of pregnancy related heart failure hospitalisations took place during the same time.. In the study, published in the journal Circulation: Heart Failure, the team analysed more than 50 million pregnancy-related hospitalisations.. The results showed that there was a 7.1 per cent increase each year in heart failure diagnoses among postpartum hospitalisations.. In addition, heart failure rates during the antepartum period, or prior to delivery, increased by an ...
Heart Failure Diagnosis and Investigation. Cardiac Failure | Patient
Heart failure is a clinical syndrome, learn about Heart Failure Diagnosis and Investigation on our Heart Failure Diagnosis and Investigation page
Get PDF - Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure...
Whellan, D.J.; Ousdigian, K.T.; Al-Khatib, S.M.; Pu, W.; Sarkar, S.; Porter, C.B.; Pavri, B.B.; O'Connor, C.M., 2010: Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study
The patient perspective: quality of life in advanced heart failure with frequent hospitalisations - Zurich Open Repository and...
End of life is an unfortunate but inevitable phase of the heart failure patients journey. It is often preceded by a stage in the progression of heart failure defined as advanced heart failure, and characterised by poor quality of life and frequent hospitalisations. In clinical practice, the efficacy of treatments for advanced heart failure is often assessed by parameters such as clinical status, haemodynamics, neurohormonal status, and echo/MRI indices. From the patients perspective, however, quality-of-life-related parameters, such as functional capacity, exercise performance, psychological status, and frequency of re-hospitalisations, are more significant. The effects of therapies and interventions on these parameters are, however, underrepresented in clinical trials targeted to assess advanced heart failure treatment efficacy, and data are overall scarce. This is possibly due to a non-universal definition of the quality-of-life-related endpoints, and to the difficult standardisation of the ...
Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure<...
TY - JOUR. T1 - Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure. AU - Chen, Horng Haur. AU - Redfield, Margaret May. AU - Nordstrom, Lynda J.. AU - Horton, Darlene P.. AU - Burnett, John C Jr.. PY - 2004/4. Y1 - 2004/4. N2 - Background Brain natriuretic peptide (BNP) is a cardiac hormone with vasodilating, natriuretic, renin-angiotensin-aldosterone-inhibiting and lusitropic properties. We have demonstrated that acute subcutaneous (SQ) administration of BNP in experimental congestive heart failure results in elevation of plasma BNP and its second messenger 3′,5′-cyclic guanosine monophosphate (cGMP) with natriuresis and reduction in cardiac filling pressures. Furthermore, chronic subcutaneous BNP in experimental congestive heart failure also resulted in increases in cardiac output and decreases in pulmonary capillary wedge pressure and systemic vascular resistance. Methods The objective of the current study was to assess the safety and efficacy of ...
Heart Failure Management | Cardiovascular CME Conferences
Heart Failure Management for Nurse Practitioners, Physician Assistants & Primary Care Providers delivers a review of diagnosing & managing heart failure.
dental care health | Heart Failure: Frequently Asked Questions
According to the American Heart Association, nearly five million Americans are living with heart failure and 550,000 new cases are diagnosed each year. Heart failure is a serious condition that often is misunderstood. The questions below are intended to help clear up some misperceptions about this condition and its complications.. Q. What is heart failure? A. Heart failure does not mean that your heart has stopped or is about to stop. It is a serious condition in which the heart doesnt pump blood through your body as well as it should. Your heart still beats, but it pumps less nutrient- and oxygen-rich blood to the rest of your body. Because of this, heart failure can make you feel tired or weak. Heart failure also can cause swelling and fluid buildup in your legs, feet and even your lungs. Fluid buildup in your lungs often is referred to as congestion, which is why heart failure is sometimes called congestive heart failure (CHF). At times, patients may require hospitalization to treat a ...
congestive heart failure recipes
Closed on Sundays. May 4, 2016 - Explore Carla Nixs board Recipes - Congestive Heart Failure and Diabetic, followed by 361 people on Pinterest. Treatments options include diet, medication, exercise, and weight loss. Chef Don created the first dietary approach to reversing heart disease as well as hypertension. Congestive heart failure effects about 5 million people in the United States and is responsible for more than 300,000 deaths annually, according to the website MedlinePlus. According to Ayurveda congestive heart failure is known as hridya avrodh. Customer Service Source: Allina Healths Patient Education Department, Heart Failure, fifth edition. Add minced garlic and minced habeneros and cook another minute. Dallas, TX 75231 This dog food recipe for congestive heart failure does involve a good amount of prep work. Share. 500 Low Sodium Recipes Lose The Salt Not Flavor In Meals Congestive heart failure the best food tips for heart failure american heart association low salt cookbook 4th ...
Systolic Heart Failure Treatment
In addition to the standard medications listed above, many other drugs may be used in certain kinds of patients. Additional medications may be needed, for example, when a woman has another condition that requires special treatment to prevent heart failure complications, or because standard medications are not enough to control severe heart failure symptoms.. Women who recently had a heart attack may receive aldosterone antagonists, a class of drugs that is similar to ACE inhibitors and ARBs. Aldosterone antagonists can prevent further changes to the hearts structure in patients who have reduced blood flow to the heart, reducing the need for hospitalization and improving survival.. Those with other existing heart disease, such as coronary artery disease, valve disease, or atrial fibrillation will take blood thinning drugs or aspirin to reduce the risk of dangerous blood clots and future heart damage that could make heart failure worse.. Digitalis, a drug that increases the strength of the heart ...
Survival of patients with severe congestive heart failure treated with oral milrinone - Fingerprint - Albert Einstein...
Fingerprint Dive into the research topics of Survival of patients with severe congestive heart failure treated with oral milrinone. Together they form a unique fingerprint. ...
Roche - NT-proBNP-guided therapy reduces cardiovascular event rates and improved quality of life in heart failure patients
03 November 2011. Positive study results promote a new paradigm in the management of heart failure. In the recently published PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial1, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death. Patients with chronic systolic heart failure (left ventricular ejection fraction ,40%) were randomized to one of two treatment approaches: a standard-of-care arm, where patients received aggressive guideline-compliant heart failure care, or an NT-proBNP arm, where patients were treated with similar aggressive clinical care, but with a simultaneous goal to decrease and maintaining NT-proBNP concentrations to a level below 1,000 pg/mL, a value which previous studies have shown the cardiovascular event risk in heart failure to ...
Heart Failure and Cardiomyopathy Center | Stony Brook Heart Institute
At the Stony Brook Heart Failure and Cardiomyopathy Center, we recognize that excellent heart failure care involves putting you in control of your condition with the help of your dedicated heart failure team. For many patients, heart failure is a chronic condition that requires long-term, well-managed care with doctors and nurses specially trained to evaluate and treat even the most complex forms of heart failure.. What is Cardiomyopathy?. Cardiomyopathy is any disease of the heart muscle that impairs the ability of the heart to pump normally. Cardiomyopathy may result in heart failure, where the heart cant pump as much blood as the body needs.. What is Heart Failure?. Heart failure means that your heart is not pumping blood through the heart and around the body as well as it should. It does not mean that your heart has stopped or is about to stop. In a healthy heart, the strong muscular walls both squeeze and relax in order to pump blood throughout the body. Learn more about heart failure ...
Chronic heart failure: time to recognise this major public health problem | The Medical Journal of Australia
The Canberra Heart Study findings are a wake-up call to those unaware of the extent of the condition. Chronic heart failure is a major and growing public health issue that affects all Western countries. Accordingly, many countries (eg, Scotland1 and Sweden2) systematically monitor its population prevalence and overall impact on the health care system. However, public awareness of the condition remains low.3 Unfortunately, in Australia, apart from sporadic initiatives such as the NSW Chronic Care Collaborative, heart failure remains the Cinderella of health issues - hardly registering on the radar of key health care providers, regulators, relevant government bodies and the general public. For example, less than one in five eligible patients receives specialist heart failure management after hospitalisation for acute heart failure.4 Undoubtedly this is at least partly explained by the fact that we do not know the true magnitude of the problem in Australia. It is time for us to recognise heart ...
Updated Heart Failure Treatment Guidelines Issued - Health Junior
An updated guideline adds two new types of drugs to the list of treatment options for heart failure.. In people with the condition, the heart cant pump enough blood throughout the body.. The two new treatments in the updated guidelines are an angiotensin receptor-neprilysin inhibitor (valsartan/sacubitril), sold as Entresto, and a sinoatrial node modulator (ivabradine), sold as Corlanor, according to the American College of Cardiology, the American Heart Association and the Heart Failure Society of America.. Previously recommended drugs for these patients include angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers, beta blockers and diuretics.. Treatment options for patients with heart failure have expanded considerably. There is more hope than ever before for patients with heart failure, guideline update committee vice chair Dr. Mariell Jessup said in a news release from the heart groups. She is a professor of medicine at the University of Pennsylvania School of ...
Influence of predictive modeling in implementing optimal heart failure therapy<...
TY - JOUR. T1 - Influence of predictive modeling in implementing optimal heart failure therapy. AU - Prasad, Hari. AU - Sra, Jaspinder. AU - Levy, Wayne C.. AU - Stapleton, Dwight D.. PY - 2011/3. Y1 - 2011/3. N2 - INTRODUCTION: A gap remains between evidence-based guidelines in the treatment of heart failure (HF) and current pharmacologic and device therapy. The Seattle Heart Failure Model (SHFM) is an accurate predictive tool that allows the clinician to quantitatively assess the influence of pharmacologic and device therapy on HF. The authors hypothesized that graphically demonstrating the improvement in survival using such a tool may well modify physician practice behavior. METHODS:: The authors examined 50 randomly selected patients from 10 primary care physicians having HF with a left ventricular ejection fraction ,40%. Twenty-one data elements were entered into the SHFM to create a survival estimate before and after implementation of interventions known to be beneficial, both ...
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI | Clinical Research...
Clinical trial for Acute Myocardial Infarction , Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
... heart failure/systemic hypertension, heart failure/pulmonary hypertension, heart failure/diabetes, heart failure/kidney failure ... Heart failure, American Heart Association - information and resources for treating and living with heart failure Heart Failure ... There are different types of heart failure: right-sided heart failure, which affects the right heart, left-sided heart failure ... One historical method of categorizing heart failure is by the side of the heart involved (left heart failure versus right heart ...
Pathophysiology of heart failure
However, the main mechanism by which left-sided heart failure causes right-sided heart failure is actually not well understood ... Over time these increases in workload will produce changes to the heart itself: The heart of a person with heart failure may ... pulmonary edema in left heart failure, peripheral edema in right heart failure). Diastolic dysfunction can be ... In heart failure, this mechanism fails, as the ventricle is loaded with blood to the point where heart muscle contraction ...
Acute decompensated heart failure
When severe heart failure is present and medicines or other heart procedures are not effective, the diseased heart needs to be ... Acute decompensated heart failure (ADHF) is a sudden worsening of the signs and symptoms of heart failure, which typically ... Heart failure due to acute aortic regurgitation is a surgical emergency associated with high mortality. Heart failure may occur ... Heart Failure Society Of America (February 2006). "Evaluation and management of patients with acute decompensated heart failure ...
Management of heart failure
Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. Clinical Guideline 5. ... January 2014). "New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart ... Krum H, National Heart Foundation of Australia and Cardiac Society of Australia & New Zealand Chronic Heart Failure Clinical ... Tønnessen T, Knudsen CW (August 2005). "Surgical left ventricular remodeling in heart failure". Eur. J. Heart Fail. 7 (5): 704- ...
Alliance for Heart Failure
The Alliance for Heart Failure's mission is to achieve better outcomes for people with heart failure by ensuring timely ... British Heart Failure Nurses Forum and British Society for Heart Failure) and Joel Rose from Cardiomyopathy UK. They have a 12- ... Focus on Heart Failure' report and makes ten new recommendations to improve heart failure care and patient outcomes. The report ... Heart Failure: A call to action was developed with input from heart failure specialists, patient groups, and professional ...
High-output heart failure
... is a heart condition that occurs when the cardiac output is higher than normal due to increased ... These individuals usually have a normal systolic function but symptoms are those of heart failure. With time, this overload ... PMID 11242561 Causes of High-Output Heart Failure Healthwise Staff of WebMD. Last updated: August 2010. Accessed 10/19/2012. ( ... O'Rouke, R.A., Fuster, V. (2001). Hurst's The Heart (10 (International edition) ed.). McGraw-Hill. p. 661. ISBN 978-0-07-116296 ...
Heart Failure Society of America
The Heart Failure Society of America is an American organization of heart failure experts who have an interest in heart ... It has produced advice on categorizing heart failure and it produces guidelines including the 2010 comprehensive heart failure ... Founded in 1995, it provides a forum for experts and patients with the aim of reducing the burden of heart failure. ... In 2018, a forum was created with people of various stages of advanced heart failure and specialists in cardiology. Past ...
Heart failure with preserved ejection fraction
... (HFpEF) is a form of heart failure in which the ejection fraction - the ... Segura AM, Frazier OH, Buja LM (March 2014). "Fibrosis and heart failure". Heart Failure Reviews. 19 (2): 173-85. doi:10.1007/ ... Zile MR (May 2003). "Heart failure with preserved ejection fraction: is this diastolic heart failure?". Journal of the American ... Neither of these situations constitutes a diastolic heart failure. Stiffening of the left ventricle contributes heart failure ...
Failure to thrive
Menon, G; Poskitt, E M (December 1985). "Why does congenital heart disease cause failure to thrive?". Archives of Disease in ... Failure to thrive is more common in developing countries and is mostly driven by malnutrition due to poverty. In an example of ... Failure to thrive is not a specific disease, but a sign of inadequate weight gain. In veterinary medicine, FTT is also referred ... Failure to thrive is most commonly diagnosed before two years of age, when growth rates are highest, though FTT can present ...
Complications of chronic failure also include heart disease, high blood pressure, and anemia. Causes of acute kidney failure ... Kidney failure can be divided into two categories: acute kidney failure or chronic kidney failure. The type of renal failure is ... Kidney failure is classified as either acute kidney failure, which develops rapidly and may resolve; and chronic kidney failure ... Stages of kidney failure Chronic kidney failure is measured in five stages, which are calculated using the person's GFR, or ...
Deaths in September 2019
... heart failure. Daniel Johnston, 58, American singer-songwriter ("Walking the Cow") and visual artist, heart attack. Annette ... Robert Boyd, 91, American journalist (Knight Ridder) and bureau chief, Pulitzer Prize winner (1973), heart failure. Wayne Brown ... heart failure. Sid Haig, 80, American actor (The Devil's Rejects, Jason of Star Command, THX 1138), complications from a lung ... heart failure. Olav Skjevesland, 77, Norwegian Lutheran prelate, Bishop of Agder og Telemark (1998-2012). Carlos Squeo, 71, ...
Braunwald E (February 2013). "Heart failure". JACC. Heart Failure. 1 (1): 1-20. doi:10.1016/j.jchf.2012.10.002. PMID 24621794. ... "Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure". Journal of the American ... "Identification of serum soluble ST2 receptor as a novel heart failure biomarker". Circulation. 107 (5): 721-6. doi:10.1161/01. ... As a result, the heart is subjected to greater stress in the presence of high levels of soluble ST2. The gene is found on the ...
Deaths in July 2009
Thomas N. Schroth, 88, American editor (Congressional Quarterly), founder of The National Journal, heart failure. José Carlos ... Mollie Sugden, 86, British actress (Are You Being Served?), heart failure. Rupert Thorneloe, 39, British soldier, Commanding ... Marcey Jacobson, 97, American photographer of indigenous peoples in Mexico, heart failure. James E. King, 69, American ... John Keel, 79, American ufologist and writer (The Mothman Prophecies), heart failure. Barbara Margolis, 79, American prisoners ...
Deaths in April 2014
Nina Cassian, 89, Romanian poet, heart attack. Joe Curl, 59, American basketball coach (University of Houston), heart failure. ... Hal Cooper, 91, American television director and producer (I Dream of Jeannie, Maude, Gimme a Break!), heart failure. Edna Doré ... Wayne Henderson, 74, American jazz trombonist (The Jazz Crusaders) and record producer, heart failure. Rhondda Alder Kelly, 87 ... Stanislaus Okurut, 84, Ugandan politician, Minister of Labour, Sports and Transport, heart failure. John Pinette, 50, American ...
Deaths in October 2017
Donald Bain, 82, American writer (Coffee, Tea or Me?), heart failure. Rosaura Barahona, 75, Mexican journalist and feminist ... heart attack. Jim Patterson, 67, American politician, member of the Alabama House of Representatives (since 2010), heart attack ... heart attack. Mary Reveley, 77, British racehorse trainer. M. V. Sridhar, 51, Indian cricketer (Hyderabad), heart attack. ... Bill Puterbaugh, 81, American racing driver (USAC). M. V. S. Haranatha Rao, 70, Indian playwright and actor, heart attack. ...
"Heart Failure". Pathobiology of Human Disease. Academic Press. pp. 971-994. ISBN 978-0-12-386457-4. Retrieved 2 November 2021. ... Sarcomeres are added in parallel, as for example occurs in hypertrophic cardiomyopathy. In the heart, ... The consequence is a decrease in ventricular compliance and diastolic dysfunction, followed eventually by ventricular failure ... concentric hypertrophy is related to increased pressure overload of the heart, often due to hypertension and/or aortic stenosis ...
Deaths in November 2010
Ken Yuasa, 95, Japanese World War II surgeon, heart failure. Petros Hanna Issa Al-Harboli, 64, Iraqi Chaldean Catholic Bishop ... Jerry Bock, 81, American musical theater composer (Fiddler on the Roof, Fiorello!), heart failure. Kenneth Brown, 77, American ... Smaro Stefanidou, 97, Greek actress, heart failure. Hedy Stenuf, 88, Austrian Olympic figure skater. András Ádám-Stolpa, 89, ... Shirley Verrett, 79, American operatic mezzo-soprano, heart failure. Fernando Bastos de Ávila, 92, Brazilian Roman Catholic ...
2019 in Latin music
... heart failure. September 15 - Roberto Leal, 67, Portuguese-Brazilian singer, skin cancer. September 19 - María Rivas, 59, ... August 21 - Celso Piña, 66, Mexican cumbia singer, composer and accordionist, heart attack. September 4 - Elton Medeiros [pt], ... heart attack) June 22 - Paulo Pagni [pt], 61, Brazilian drummer (RPM), pulmonary fibrosis. July 6 - João Gilberto, 88, ...
2021 in Colombia
... heart attack. 29 March - Antonio Caro, 71, conceptual artist; heart failure. 11 April - Guillermo Berrio, 53, footballer; ...
Deaths in September 1994
Eijirō Tōno, 86, Japanese actor (Seven Samurai, Tokyo Story, Tora! Tora! Tora!), heart failure. Robert Austerlitz, 70, Romanian ... Arthur Siegel, 70, American songwriter, heart failure. John Stevens, 54, English drummer. Woodie Wilson, 68, American stock car ... Patrick O'Neal, 66, American actor (The Way We Were, The Stepford Wives, Under Siege), respiratory failure. Frank Broome, 79, ... Harry Saltzman, 78, Canadian theatre and film producer, heart attack. Robert L. F. Sikes, 88, American politician. K. A. ...
Deaths in August 2012
Robert W. McNitt, 97, American U.S. Navy rear admiral, dean of admissions at the U.S. Naval Academy, heart failure. Édgar ... Claire Malis, 69, American actress (One Life to Live, From Here to Eternity, The Facts of Life), heart failure and pneumonia. ... Von Freeman, 88, American hard bop jazz tenor saxophonist, heart failure. Lucy Gallardo, 82, Argentine-born Mexican film and ... William Windom, 88, American actor (Murder She Wrote, To Kill a Mockingbird, Star Trek), heart failure. Katsumi Yamauchi, 100, ...
2018 in Mexico
July 26: Alfredo del Águila (83), soccer player (b. 1935). July 30: Claudia Heinze, model; heart failure. July 31: Rafael ... November 18: Héctor Beltrán Leyva 53, Mexican drug lord, died of a heart attack (b. 1965) November 19: Isidro Olace (83), actor ... May 15 José Lavat, 69, Mexican voice actor, renal failure. May 16: Alejandro Caballero Vértiz, lawyer and judge. May 17: Hernán ... March 21: Saúl Montoya Beltrán (66), baseball player; heart attack (b. 1951). March 22: Jaime Puga, actor and singer. Adela ...
2021 in East Africa
... heart failure. March 29 - Sarah Onyango Obama, 99, Kenyan educator and philanthropist, grandmother of former U.S. President ...
Deaths in March 2016
... heart failure. Dame Zaha Hadid, 65, Iraqi-born British architect, heart attack. Imre Kertész, 86, Hungarian writer, laureate of ... Gavin Christopher, 66, American R&B/hip-hop musician, songwriter and producer, heart failure. Martin Crowe, 53, New Zealand ... Ge Cunzhuang, 87, Chinese actor, heart failure. Adriana Innocenti, 89, Italian actress (Eye of the Cat, Lobster for Breakfast, ... heart failure. Masanobu Deme, 83, Japanese film director (Station to Heaven, Baruto no Gakuen). Darryl Hunt, 50, American ...
List of shipwrecks in the Thunder Bay National Marine Sanctuary
"Heart Failure". National Oceanic and Atmospheric Administration. Retrieved November 16, 2019. "Isaac M. Scott". USGenNet Great ...
Health effects of coffee
"Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis". Circulation. Heart Failure. 5 (4): 401- ... A 2012 meta-analysis concluded that people who drank moderate amounts of coffee had a lower rate of heart failure, with the ... Wu JN, Ho SC, Zhou C, Ling WH, Chen WQ, Wang CL, Chen YM (November 2009). "Coffee consumption and risk of coronary heart ... September 2021). "2021 ESC Guidelines on cardiovascular disease prevention in clinical practice". European Heart Journal. 42 ( ...
NSAIDs and the Development of Congestive Heart Failure in Elderly Patients NSAIDs May Increase Risk for Worsening Heart Failure ... heart failure; after coronary artery bypass surgery; and during the third trimester of pregnancy. Known mild side effects of ... Symptoms of overdosing include kidney failure, gastrointestinal problems, bleeding, rashes, confusion, hallucinations, vertigo ...
Deaths in April 2007
... heart failure. Archie Campbell, 65, Canadian jurist. James B. Davis, 90, American founder of The Dixie Hummingbirds, heart ... heart failure. Audrey Santo, 23, American brain-injured girl claimed to have performed miracles, cardio-respiratory failure. ... heart failure. Kevin Crease, 70, Australian television newsreader, cancer. Walter Hendl, 90, American conductor, heart and lung ... Kitty Carlisle, 96, American actress (A Night at the Opera), TV personality (To Tell the Truth) and singer, heart failure. ...
Deaths in February 2011
... heart failure. Charles E. Silberman, 86, American journalist and author (Criminal Violence, Criminal Justice), heart attack. ... Ching Arellano, 50, Filipino actor and comedian, heart failure. Kevin Barry, Sr., 74, New Zealand boxing coach, after long ... David F. Friedman, 87, American film producer (Blood Feast), heart failure. Cecil Kaiser, 94, American Negro league baseball ... Tura Satana, 72, American actress (Faster, Pussycat! Kill! Kill!), heart failure. Earl Irvin West, 90, American church ...
Starr had known that heart disease could precede congestive heart failure by several years, but at the time heart disease was ... Albert Lasker Award of the American Heart Association (1957) "for fundamental contributions to knowledge of the heart and the ... Heart Failure. Washington: Hemisphere Pub. Corp. ISBN 978-0-07-021118-6. LCCN 78059673. Starr, Isaac; Alfred Newton Richards ( ... where he later became a heart disease specialist, motivated by the heart disease-related death of his mother. After returning ...
... and died from heart failure on January 18, 1986, in Buenos Aires. In February 2011 it was reported that many artifacts germane ... At the same time, the themes of tango lyrics evolved from light-hearted ribaldry into more complex stories delving on love and ...
Deaths in December 2014
... heart failure. Carlos Mamery, 54, Puerto Rican music producer and television personality (Idol Puerto Rico), heart attack. A. J ... Norman Bridwell, 86, American author and cartoonist (Clifford the Big Red Dog), heart failure. James Clarke, 91, English ... Horacio Ferrer, 81, Uruguayan poet, broadcaster and tango lyricist, heart failure. Chris Hall, 64, Canadian lacrosse coach ( ... Raymond M. Durkin, 78, American politician, complications related to heart failure and emphysema. Mike Elliott, 68, British ...
One for the Money (film)
Desperate for money, she recovers her first fugitive, delivering her nudist neighbor to the police for failure to appear. In ... right where Heigl's heart should be." Andrew Barker from Variety wrote about Heigl having "an almost standoffish lack of ... a feeling which is only reinforced by its late-January release and failure to be screened for critics." Jeff Otto from ... 2012 and was both a critical and commercial failure. The film received extremely negative reviews from critics, with many ...
Ariosa v. Sequenom
He blames the assertedly disastrous result on the Federal Circuit's failure to "consider the claim as a whole," instead of ... he panel's decision striking down Sequenom's noninvasive prenatal test strikes at the very heart of the patent system. ...
... died of congestive heart failure at Laurel Regional Hospital in Laurel, Maryland, on August 9, 2011, at the age of 91 ...
Heart failure was given as the cause of death. On Boxing Day 1949 the "Gwyn Nicholls Memorial Gates" were officially opened at ...
Fabula Nova Crystallis Final Fantasy
The game is an action role-playing game with a battle system similar to those from the Kingdom Hearts series and Type-0. The ... RPG Site's Chelsi Laire called the subseries "a series of successes and failures, but mostly the latter" due to its troubled ... Versus XIII's development was headed by the team behind the console Kingdom Hearts games. Like XIII, the game was a PS3 ... Etro gives humans pieces of chaos that become their "hearts". Because humans held chaos within them, they maintained the ...
... "real failure," and to the work he did as, "political hackery." He said that if he had taken a job offer with Deloitte, ... www.timescolonist.com/news/local/how-a-victoria-kid-ended-up-at-heart-of-facebook-data-mining-story-1.23206550 Archived 2019-01 ... Jack Knox, 'How a Victoria kid ended up at heart of Facebook data-mining story', The Times Colonist, 20 March 2018 https:// ...
Prostaglandin-endoperoxide synthase 2
... such as heart failure, myocardial infarction, and stroke. Studies with human pharmacology and genetics, genetically manipulated ... It sticks platelets together and promotes clotting; inhibiting this helps prevent heart disease. On the other hand, PTGS2 (COX- ... Low-dose aspirin protects against heart attacks and strokes by blocking PTGS1 (COX-1) from forming a prostaglandin called ... Mechanisms of COX-2 inhibitor risk to heart disease". Life Sciences. 88 (1-2): 24-30. doi:10.1016/j.lfs.2010.10.017. PMC ...
I want to say in the most forceful way I can: I certainly hope so." In the wake of the Lincoln failure, former FHLBB chair Gray ... A delay was also caused when Pryor suffered a heart attack in April 1991, and was replaced on the committee by Jeff Bingaman. ... The U.S. savings and loan crisis of the 1980s and early 1990s was the failure of 747 savings and loan associations in the ... Gonzalez held 50 hours of hearings into the Lincoln failure and associated events. By November 1989, the estimated cost of the ...
23-24 ISBN 978-0-415-35385-4. Johnson, Walter, 1967- (14 April 2020). The broken heart of America : St. Louis and the violent ... looked to the US for guidance and were not willing to arm the enemies of the US with more propaganda about its failures in ... Self 2012, p. 79 Bibby, Michael (1996). Hearts and Minds: Bodies, Poetry, and Resistance in the Vietnam Era. Perspectives on ... The Broken Heart of America, Harvard professor Walter Johnson wrote that on many occasions throughout the history of the ...
His lack of influential allies in Whitehall led to the failure of this mission. At this time, many members of ... ISBN 978-1-137-45242-9. The question at the heart of this volume is the reliability, indeed, the fundamental honesty, of Donald ... such as parts of the Italian grammar to be learned by heart, to be performed by the loser before their next meeting. Franklin ...
List of ICD-9 codes 390-459: diseases of the circulatory system
... acute 428.2 Systolic heart failure 428.3 Diastolic heart failure 428.4 Heart failure, combined, unspec. 429 Ill-defined ... dysrhythmia unspecified Gallop rhythm 428 Heart failure 428.0 Congestive heart failure unspecified 428.1 Left heart failure ... 390 Rheumatic fever without mention of heart involvement 391 Rheumatic fever with heart involvement 391.9 Rheumatic heart ... chronic ischemic heart disease 414.0 Coronary atherosclerosis 414.1 Aneurysm and dissection of heart 414.10 Aneurysm of heart ( ...
Free German Youth
As the sole official representative of East German youth, the FDJ's main objective was to win over the hearts and minds of ... "failure of the organisation" because "the concentrated presence of former full-time officials" prevented a "radical break with ...
Eliot A. Cohen
If we fail in Iraq-and I don't think we will-it won't be because the American people lack heart, but because leaders and ... The Anatomy of Failure in War, Free Press, 1990, ISBN 0-02-906060-5. With Thomas A. Keaney, Gulf War Air Power Survey Summary ...
In May 1966, after a heart attack, the 42-year-old Savundra sold his FAM shares to his FAM directors. Led by Stuart de Quincy ... His only criminal offence in Ceylon was the failure to pay an Inland Revenue bill based on earnings from some of his economic ... victims of the insurance-company failure) as "peasants" and claimed "no moral responsibility" for what had happened. Frost (who ...
It has the distinction of being the work Johnson considered his greatest failure. Since his death, the critical consensus has ... "the heart begins after a while to sink except in the most resolute Johnsonian, and sometimes even then." Boswell 1980, p. 1068 ... and that Irene was a failure because Johnson's best poetry (such as The Vanity of Human Wishes) was "a poetry of statement, ...
Walter T. Kerwin Jr.
On July 11, 2008 in Alexandria, Virginia of respiratory failure. He was preceded in death by his first wife, Barbara in 1980. ... the Navy Commendation Medal and the Purple Heart. Kerwin's service awards include the American Defense Service Medal, European ...
Despite the failures of his Bolivian post, Appleton continued his interest in international relations by taking up a position ... Industrialized Lowell is criticized for commercialism, as "not in such places are republican spirits and Spartan hearts best ...
Cauchon died abruptly of heart failure at the age of 71 on 15 December 1442 in Rouen. He was buried in Lisieux Cathedral ...
... died in Bergamo on 25 March 2000, due to heart failure. His work as planetary scientist changed the view of the ...
According to his brother Paul, the cause of death was heart failure. Also according to Paul, Joe was never healthy again after ...
He was appalled by the attitude of the Canadian government towards the native peoples and its failure to adhere to its ... at heart, and made him an honorary member of the order. In 1883, he wrote a Blackfoot dictionary and grammar for Oblate Fathers ... Scollen took great care to avoid politics but following the failure of the Dominion government to fulfill its treaty ... obligations under the various treaties.(These failures contributed to the 1885 North-West Rebellion/Resistance) He had seen the ...
Alberto Martínez (footballer, born 1950)
Martínez died on 1 December 2009 of heart failure, at the age of 59. Martínez held Austrian citizenship. His son is the ...
Yuki Onishi (chef)
Onishi died on September 23, 2022, reportedly of acute heart failure. Hirwani, Peony (2022-09-25). "Founder of world's first ...
... which recognises the failure within oneself, not even as much in the sin committed, as in the very being. I was trained even ... to the work of the heart and of the mind'. They were then joined by Sister Katharine. Shortly before the Monastery moved from ...
Erin Gee (artist)
"VR and The Failure of Self Help Technology". Canadian Art. Canadian Art. Retrieved 2018-10-24. "Current Members (18-19)". Locus ... As part of her work, Gee has become a self-taught robotics specialist, measuring "actors' sweat production, heart rate, blood ... for example creating music and moving machinery inspired by recordings of heart rate and anxiety. Her works have been shown and ... with an oculus headset and a biosensor connected to the user's hand would measure changes in their skin conductance and heart ...
Nobody Home (film)
The blonde young man also takes refuge there, down at heart both by the failure to win Frances and the fact that, in order to ...
Zhang submitted a report on the failures of the campaign, and as a result Wang was removed from his office. Zhang was ... Why should there be defensive bulwarks to allow soldiers to have fearful hearts? It was only later when another general, Chang ...
But after the failure of the Rising and the subsequent executions of the leading revolutionaries the tricolour and 'The ... Keenan, Dan (9 January 2014). "Loyalists line up to learn cúpla focail at language classes in heart of east Belfast". Irish ...
TRANSFORM-HF: Loop Diuretics Show No Difference in Mortality and Hospitalizations for Heart Failure | Yale School of Medicine
... which explored the effects of two different therapies on heart failure outcomes, were featured during the first ... Director of Heart Failure Research, Cardiovascular Medicine; Co-Director Heart & Vascular Center Clinical Research, Heart & ... The results of the TRANSFORM-HF study, which explored the effects of two different therapies on heart failure outcomes, were ... Nevertheless, the current guidelines for diuretic agents which are a mainstay of therapy for heart failure have remained ...
Heart Failure | cdc.gov
... a serious condition when the heart cannot pump enough blood and oxygen to support other organs in your body. ... medicines to treat heart failure, and missed days of work.. Deaths from Heart Failure Vary by Geography. Heart failure is more ... Heart failure happens when the heart cannot pump enough blood and oxygen to support other organs in your body. Heart failure is ... Facts About Heart Failure in the United States. *About 6.2 million adults in the United States have heart failure.1 ...
Heart Failure Differential Diagnoses
Heart failure develops when the heart, via an abnormality of cardiac function (detectable or not), fails to pump blood at a ... At high risk for heart failure but without structural heart disease or symptoms of heart failure ... Diastolic heart failure may be the most common form of heart failure in the US population.  Alterations in ventricular- ... In heart failure, a history of an acute cardiac event or of progressive symptoms of heart failure is usually present. The ...
Heart failure: MedlinePlus Medical Encyclopedia
Heart failure is a condition in which the heart is no longer able to pump oxygen-rich blood to the rest of the body efficiently ... Congestive heart failure; Left-sided heart failure; Right-sided heart failure - cor pulmonale; Cardiomyopathy - heart failure; ... Heart failure is present when:. *Your heart muscle cannot contract very well. This is called systolic heart failure, or heart ... New, abnormal heart rhythms Most of the time, heart failure is a chronic illness. Some people develop severe heart failure. At ...
New biochemical markers in chronic heart failure
El Bindary, E.M. & Darwish, A.Z. (2001). New biochemical markers in chronic heart failure. EMHJ - Eastern Mediterranean ... We conclude that cytokine neuroendocrine activation may form part of advanced stage heart failure. It may also be responsible ... and TNF-alpha and BMI and leptin and BMI were negatively correlated in stages III and IV of heart failure. ... in 80 male patients who presented with chronic heart failure [mean age: 47 +/- 4 years] at Tanta University Hospital. Plasma ...
Timing of Menopause May Affect Heart Failure Risk
Also, women who never gave birth seemed at increased risk for a type of heart failure in which the left side of the heart fails ... Having more children was not associated with heart failure risk, according to the study published May 15 in the Journal of the ... Timing of Menopause May Affect Heart Failure Risk Women whose periods end early and those who never give birth seem at added ... In the study, earlier menopause was associated with increased risk of heart failure, and this link was stronger in women who ...
Browsing by Subject "Heart Failure"
Johns Hopkins Health - Heart Failure Care Checklist
Heart failure-also known as congestive heart failure, or CHF-is a chronic but manageable condition that affects nearly 6 ... Heart failure-also known as congestive heart failure, or CHF-is a chronic but manageable condition that affects nearly 6 ... director of the Johns Hopkins Bayview Comprehensive Heart Failure Program, offers these guidelines to help heart failure ... Watch for signs that your heart failure is getting worse, such as shortness of breath, or swelling in the legs or abdomen. ...
Congestive Heart Failure
... An overview of what Congestive Heart Failure is. This page covers topics such as causes, who is at ... You just viewed Congestive Heart Failure. Please take a moment to rate this material. ... CHF, Congestive Heart Failure, heart failure Disciplines:. * Science and Technology / Health Sciences / Geriatrics ...
Congestive Heart Failure (for Parents) - HackensackUMC
Congestive heart failure (CHF) is when blood backs up in the heart. ... Heart failure is when the heart cant pump blood the way it should. ... Treatment can help with heart failure and sometimes control it.. What Is Congestive Heart Failure?. Congestive heart failure ( ... What Is Heart Failure?. Heart failure is when the heart cant deliver as much blood to the body as it should. If that happens, ...
Watch Heart Failure Explained | WIRED Brand Lab | WIRED
Heart Failure is a big deal and often misunderstood. Learn what heart failure is, how its projected to get bigger in the ... Heart Failure Explained , WIRED Brand Lab. *About. BRANDED CONTENT , Produced by WIRED Brand Lab with Novartis , Heart Failure ... Learn what heart failure is, how its projected to get bigger in the coming years and how you can treat it. ... that results in one kind of heart failure, known as. heart failure with reduced ejection fraction, or HFrEF. ...
Heart failure | School of Biomedical Engineering & Imaging Sciences | King's College London
Heart Failure? | Diabetes Daily Forums
Anyone here with congestive or diastolic heart failure? ... Was diagnosed with heart failure last year. I am struggling ... I was told in October of 2021 that I had dyastolic heart failure and at last cardiologist visit in Jan, I was told it has ... I was told in October of 2021 that I had dyastolic heart failure and at last cardiologist visit in Jan, I was told it has ... I guess CHF is more common, and different than diastolic heart failure and the two really cant be lumped together.. And I ...
Decompensated heart failure: Symptoms, treatment, and more
Decompensated heart failure is severe heart failure that requires immediate medical attention. Symptoms include breathlessness ... Acute decompensated heart failure. Acute decompensated heart failure is the most common form of acute heart failure and occurs ... Can heart failure cause swollen feet?. Heart failure can cause a buildup of fluid in the body, resulting in swollen feet, ... adults with heart failure in the United States. The organization also states that heart failure was responsible for more than ...
Why does diabetes cause heart failure? | EurekAlert!
... people without heart failure, people with heart failure who also had diabetes and people with heart failure who did not have ... more in diabetic heart failure patients than it does in people who either dont have heart failure or have heart failure ... The cells work in concert to make the heart contract and relax with each beat. In patients suffering from heart failure, heart ... diabetes can cause heart failure. The findings could lead to medications to treat and perhaps prevent heart failure in diabetes ...
Advanced Heart Failure and Transplantation Fellowship | Pediatrics
Advanced Heart Failure and Transplantation Fellowship. Overview. The Stollery Childrens Hospital is currently the institution ... heart failure consults and transplant assessments. *outpatient transplant clinic once weekly and additional ad hoc clinics for ... Since 2013, an independent service for heart failure and cardiomyopathy was initialized. We are working in close continuous ... Western Canadian transplant tele-health rounds weekly and heart failure rounds every second weekly (fellow presenting the local ...
How Do You Check for Congestive Heart Failure?
Should congestive heart failure be thought to be caused by atherosclerotic heart disease, risk factors for heart disease may be ... Explore heart disease diagnosis, treatment, and preventing heart failure. Read more: Heart Disease: Symptoms, Signs, and Causes ... Listening to the heart sounds may uncover abnormal beats called gallops that are heard in heart failure. Murmurs may help ... Heart Disease: Symptoms, Signs, and Causes. What is heart disease (coronary artery disease)? Symptoms of heart disease include ...
cardiovascular disease - Ventricular dysfunction in heart failure | Britannica
... called left ventricular heart failure, or left-sided heart failure), a series of compensatory reactions are initiated that may ... One mechanism of compensation associated with left ventricular failure is left ventricular enlargement, which can increase the ... blood to the lungs and body means that even a slight decrease in ventricular efficiency can have a significant impact on heart ... Right ventricular heart failure (sometimes called right-sided heart failure) results in right-sided alterations in the ...
Heart Failure - What Is Heart Failure? | NHLBI, NIH
Learn about the symptoms, causes, risk factors, and treatments for heart failure. ... Heart failure is a condition that occurs when your heart cant pump enough blood for your bodys needs. ... The term "heart failure" does not mean that your heart has stopped. However, heart failure is a serious condition that needs ... Heart failure, also known as congestive heart failure, is a condition that develops when your heart doesnt pump enough blood ...
Serum albumin and mortality in acutely decompensated heart failure
... Am Heart J. 2010 Dec;160(6):1149-55. doi: 10.1016/j.ahj. ... Background: Although hypoalbuminemia has been associated with decreased survival in chronic systolic heart failure (HF), its ... role for prognosticating outcomes in those with acutely decompensated heart failure (ADHF) has not been established. ...
Congestive Heart Failure Questions & Answers - Drugs.com
Ask questions and get answers from people sharing their experience with Congestive Heart Failure. ... Displaying 38 questions associated with Congestive Heart Failure.. Metoprolol Succinate vs Tartrate - Whats the difference ... I have been diagnosed with congestive heart failure. This of course causes retention of fluids in my body when I ingest ... Join the Congestive Heart Failure group to help and get support from people like you. ...
Palliative and Hospice Heart Failure Care Certification | American Heart Association
... for evaluating agencies against the American Heart Associations science-based guidelines and standards for heart failure ... The American Heart Association will be launching a certification for palliative/hospice heart failure. This certification ... The agency is recognized by the AHA, based on professional evaluation criteria designed by heart failure and palliative/hospice ... Confidence their heart failure treatment is coordinated from admission and throughout palliative/hospice care ...
MSc Heart Failure
Heart failure | CTSNet
Comparing CABG to medical therapy groups, the authors note that CABG reduced all cause, cardiovascular, and heart failure ... This was due to fewer total cardiovascular hospitalizations, the majority due to heart failure. ... growth and replication of cardiomyocytes derived from stem cells is insufficient to permit regeneration of functioning heart ...
Heart Failure Society of America (HFSA) 20th Annual Scientific Meeting
... : Read clinically focused news coverage of key ... Presentation: Hyperkalemia: Implication for heart failure management. Date: September 18, 2016. Presentation: Case discussion- ... Heart Failure Society of America (HFSA) 20th Annual Scientific Meeting September 17 - 20, 2016; Orlando, Florida ... Undiagnosed AF, Subclinical Strokes May Be Common in Preserved-EF Heart Failure: ARIC Subclinical strokes in HFpEF could have ...
Diabetes Complications: Can Diabetes Lead To Heart Failure?
Diabetes can increase ones risk of chronic heart diseases such as heart failure. Heres what leads to an increased risk. ... People with heart failure and diabetes may have worse clinical results than those with heart failure alone, there are ... Here are some lifestyle changes that can significantly lower your risk of heart failure and other heart diseases:. *Regularly ... World Diabetes Day 2022: Diabetes can increase ones risk of chronic heart diseases such as heart failure. Heres what leads to ...
JCI - Mitochondrial dysfunction in pathophysiology of heart failure
Mitochondrial Ca2+ and the development of heart failure. Dysregulation of Ca2+ homeostasis is a hallmark of heart failure. ... Mitochondrial dysfunction and inflammation in heart failure. Heart failure is associated with heightened inflammatory response ... precursors in heart failure patients is required before its efficacy on heart failure progression can be determined. ... Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy. JACC Heart Fail. 2015;3(3):202 ...
Systolic vs. Diastolic Heart Failure: What's the Difference?
Types of heart failure affect the left side of the heart: systolic and diastolic. Learn more about the differences between them ... Types of heart failure. (2017).. heart.org/en/health-topics/heart-failure/what-is-heart-failure/types-of-heart-failure. ... Ejection fraction heart failure measurement. (2017).. heart.org/en/health-topics/heart-failure/diagnosing-heart-failure/ ... Both types of left-sided heart failure can lead to right-sided heart failure. Right-sided heart failure happens when the right ...
Symptoms of Canine Congestive Heart Failure
Common Causes of Dog Congestive Heart Failure. There are two common cause of congestive heart failure in dogs: degenerative ... Symptoms of Canine Congestive Heart Failure. Regardless of the cause of your dogs congestive heart failure, the symptoms will ... to heart failure. Understanding the Anatomy of Your Dogs Heart. Your dogs heart has four chambers, a left and right atrium ( ... Canine congestive heart failure happens when your dogs heart is no longer able to pump blood to the rest of his body as ...